These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 31813804)

  • 1. A longitudinal comparison of two neurocognitive test batteries in patients with schizophrenia and healthy volunteers: Time effects on neuropsychological performance and their relation to functional outcome.
    Rodriguez-Toscano E; López G; Mayoral M; Lewis S; Lees J; Drake R; Arango C; Rapado-Castro M
    Schizophr Res; 2020 Feb; 216():347-356. PubMed ID: 31813804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modafinil and cognitive enhancement in schizophrenia and healthy volunteers: the effects of test battery in a randomised controlled trial.
    Lees J; Michalopoulou PG; Lewis SW; Preston S; Bamford C; Collier T; Kalpakidou A; Wykes T; Emsley R; Pandina G; Kapur S; Drake RJ
    Psychol Med; 2017 Oct; 47(13):2358-2368. PubMed ID: 28464963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An optimal combination of MCCB and CANTAB to assess functional capacity in older individuals with schizophrenia.
    Kumar S; Mulsant BH; Tsoutsoulas C; Ghazala Z; Voineskos AN; Bowie CR; Rajji TK
    Int J Geriatr Psychiatry; 2016 Oct; 31(10):1116-23. PubMed ID: 27428251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calibration and cross-validation of MCCB and CogState in schizophrenia.
    Lees J; Applegate E; Emsley R; Lewis S; Michalopoulou P; Collier T; Lopez-Lopez C; Kapur S; Pandina GJ; Drake RJ
    Psychopharmacology (Berl); 2015 Nov; 232(21-22):3873-82. PubMed ID: 26018529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Examination of the validity of the Brief Neurocognitive Assessment (BNA) for schizophrenia.
    Fervaha G; Hill C; Agid O; Takeuchi H; Foussias G; Siddiqui I; Kern RS; Remington G
    Schizophr Res; 2015 Aug; 166(1-3):304-9. PubMed ID: 26004693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of cognitive functions in animal models of schizophrenia.
    Nikiforuk A
    Pharmacol Rep; 2018 Aug; 70(4):639-649. PubMed ID: 29894866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial aggregation of MATRICS Consensus Cognitive Battery scores in a large sample of outpatients with schizophrenia and their unaffected relatives.
    Mucci A; Galderisi S; Green MF; Nuechterlein K; Rucci P; Gibertoni D; Rossi A; Rocca P; Bertolino A; Bucci P; Hellemann G; Spisto M; Palumbo D; Aguglia E; Amodeo G; Amore M; Bellomo A; Brugnoli R; Carpiniello B; Dell'Osso L; Di Fabio F; di Giannantonio M; Di Lorenzo G; Marchesi C; Monteleone P; Montemagni C; Oldani L; Romano R; Roncone R; Stratta P; Tenconi E; Vita A; Zeppegno P; Maj M;
    Psychol Med; 2018 Jun; 48(8):1359-1366. PubMed ID: 29017620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of the MATRICS and IntegNeuro cognitive assessment batteries.
    Silverstein SM; Jaeger J; Donovan-Lepore AM; Wilkniss SM; Savitz A; Malinovsky I; Hawthorne D; Raines S; Carson S; Marcello S; Zukin SR; Furlong S; Dent G
    J Clin Exp Neuropsychol; 2010 Nov; 32(9):937-52. PubMed ID: 20455131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor structure of the MATRICS Consensus Cognitive Battery (MCCB) in schizophrenia.
    Burton CZ; Vella L; Harvey PD; Patterson TL; Heaton RK; Twamley EW
    Schizophr Res; 2013 May; 146(1-3):244-8. PubMed ID: 23507359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Healthy adolescent performance on the MATRICS Consensus Cognitive Battery (MCCB): Developmental data from two samples of volunteers.
    Stone WS; Mesholam-Gately RI; Giuliano AJ; Woodberry KA; Addington J; Bearden CE; Cadenhead KS; Cannon TD; Cornblatt BA; Mathalon DH; McGlashan TH; Perkins DO; Tsuang MT; Walker EF; Woods SW; McCarley RW; Heinssen R; Green MF; Nuechterlein K; Seidman LJ
    Schizophr Res; 2016 Apr; 172(1-3):106-13. PubMed ID: 26896388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Profile of cognitive deficits in schizophrenia and factor structure of the Czech MATRICS Consensus Cognitive Battery.
    Bezdicek O; Michalec J; Kališová L; Kufa T; Děchtěrenko F; Chlebovcová M; Havlík F; Green MF; Nuechterlein KH
    Schizophr Res; 2020 Apr; 218():85-92. PubMed ID: 32089475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive functioning in first-episode schizophrenia: MATRICS Consensus Cognitive Battery (MCCB) Profile of Impairment.
    McCleery A; Ventura J; Kern RS; Subotnik KL; Gretchen-Doorly D; Green MF; Hellemann GS; Nuechterlein KH
    Schizophr Res; 2014 Aug; 157(1-3):33-9. PubMed ID: 24888526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The MCCB impairment profile for schizophrenia outpatients: results from the MATRICS psychometric and standardization study.
    Kern RS; Gold JM; Dickinson D; Green MF; Nuechterlein KH; Baade LE; Keefe RS; Mesholam-Gately RI; Seidman LJ; Lee C; Sugar CA; Marder SR
    Schizophr Res; 2011 Mar; 126(1-3):124-31. PubMed ID: 21159492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [MATRICS consensus cognitive battery--standard for the assessment of cognitive functions in clinical trials in schizophrenia].
    Jedrasik-Styła M; Ciołkiewicz A; Denisiuk M; Linke M; Parnowska D; Gruszka A; Jarema M; Wichniak A
    Psychiatr Pol; 2012; 46(2):261-71. PubMed ID: 23214396
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The MCCB impairment profile in a Spanish sample of patients with schizophrenia: Effects of diagnosis, age, and gender on cognitive functioning.
    Rodriguez-Jimenez R; Dompablo M; Bagney A; Santabárbara J; Aparicio AI; Torio I; Moreno-Ortega M; Lopez-Anton R; Lobo A; Kern RS; Green MF; Jimenez-Arriero MA; Santos JL; Nuechterlein KH; Palomo T
    Schizophr Res; 2015 Dec; 169(1-3):116-120. PubMed ID: 26416441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Latent structure of cognition in schizophrenia: a confirmatory factor analysis of the MATRICS Consensus Cognitive Battery (MCCB).
    McCleery A; Green MF; Hellemann GS; Baade LE; Gold JM; Keefe RS; Kern RS; Mesholam-Gately RI; Seidman LJ; Subotnik KL; Ventura J; Nuechterlein KH
    Psychol Med; 2015; 45(12):2657-66. PubMed ID: 25916421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The MATRICS consensus cognitive battery in patients with bipolar I disorder.
    Burdick KE; Goldberg TE; Cornblatt BA; Keefe RS; Gopin CB; Derosse P; Braga RJ; Malhotra AK
    Neuropsychopharmacology; 2011 Jul; 36(8):1587-92. PubMed ID: 21451499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychometric characteristics of the MATRICS Consensus Cognitive Battery in a large pooled cohort of stable schizophrenia patients.
    Georgiades A; Davis VG; Atkins AS; Khan A; Walker TW; Loebel A; Haig G; Hilt DC; Dunayevich E; Umbricht D; Sand M; Keefe RSE
    Schizophr Res; 2017 Dec; 190():172-179. PubMed ID: 28433500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What is the optimal neuropsychological test battery for schizophrenia in China?
    Shi C; Kang L; Yao S; Ma Y; Li T; Liang Y; Cheng Z; Xu Y; Shi J; Xu X; Zhang C; Franklin DR; Heaton RK; Jin H; Yu X
    Schizophr Res; 2019 Jun; 208():317-323. PubMed ID: 30718121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.